We observed improved T cell infiltration, and RTT tumours were controlled in a CD8-dependent manner in both the YUMM1.7 and YUMM3.3 models (Fig. 4g, Extended Data Fig. 7k and Extended Data Fig. 8a). The gene discussed is CD8A; the disease is neoplasm.